These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 1198095)

  • 1. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
    Reddy JK; Krishnakantha TP
    Science; 1975 Nov; 190(4216):787-9. PubMed ID: 1198095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643.
    Reddy JK; Azarnoff DL; Sirtori CR
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):4-14. PubMed ID: 708142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic effects of some [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) analogs in the mouse.
    Reddy JK; Moody DE; Azarnoff DL; Tomarelli RM
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):51-7. PubMed ID: 851495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat.
    Lazarow PB
    Science; 1977 Aug; 197(4303):580-1. PubMed ID: 195342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agents.
    Moody DE; Reddy JK; Azarnoff DL
    Biochem Pharmacol; 1984 Aug; 33(16):2591-7. PubMed ID: 6431985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.
    Lalwani ND; Reddy MK; Qureshi SA; Sirtori CR; Abiko Y; Reddy JK
    Hum Toxicol; 1983 Jan; 2(1):27-48. PubMed ID: 6840792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs.
    Reddy MK; Lalwani ND; Qureshi SA; Reddy JK
    Hum Toxicol; 1982 Mar; 1(2):135-47. PubMed ID: 7173894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
    Moody DE; Reddy JK
    Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J; Svoboda D; Azarnoff D
    Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
    Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
    Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of peroxisome proliferators on intrachromosomal and interchromosomal recombination in yeast.
    Schiestl RH; Reddy JK
    Carcinogenesis; 1990 Jan; 11(1):173-6. PubMed ID: 2403857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hepatic ornithine decarboxylase by hypolipidemic drugs with hepatic peroxisome proliferative activity.
    Izumi K; Reddy JK; Oyasu R
    Carcinogenesis; 1981; 2(7):623-7. PubMed ID: 7273341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes to the integral membrane protein composition of mouse liver peroxisomes in response to the peroxisome proliferators clofibrate, Wy-14,643 and di(2-ethyl-hexyl)phthalate.
    Crane DI; Chen N; Masters C
    Mol Cell Biochem; 1988 May; 81(1):29-36. PubMed ID: 3173343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens.
    Reddy JK; Azarnoff DL; Hignite CE
    Nature; 1980 Jan; 283(5745):397-8. PubMed ID: 6766207
    [No Abstract]   [Full Text] [Related]  

  • 15. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response.
    Reddy JK; Azarnoff DL; Svoboda DJ; Prasad JD
    J Cell Biol; 1974 May; 61(2):344-58. PubMed ID: 4208071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver.
    Reddy JK; Rao MS; Azarnoff DL; Sell S
    Cancer Res; 1979 Jan; 39(1):152-61. PubMed ID: 83907
    [No Abstract]   [Full Text] [Related]  

  • 17. Partial purification and immunoreactivity of an 80 000-molecular-weight polypeptide associated with peroxisome proliferation in rat liver.
    Reddy MK; Hollenberg PF; Reddy JK
    Biochem J; 1980 Jun; 188(3):731-40. PubMed ID: 6781475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
    Reddy JK
    Am J Pathol; 1974 Apr; 75(1):103-18. PubMed ID: 4825610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.
    Warren JR; Simmon VF; Reddy JK
    Cancer Res; 1980 Jan; 40(1):36-41. PubMed ID: 6765917
    [No Abstract]   [Full Text] [Related]  

  • 20. Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.
    Lazarow PB; Shio H; Leroy-Houyet MA
    J Lipid Res; 1982 Feb; 23(2):317-26. PubMed ID: 7077146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.